|Base Year Market Size
|USD 5,627.99 Million
|Forecast Year Market Size
|USD 8486.98 Million
|Fastest Growing Market
The global vessel sealing devices market size was valued at USD 5,627.99 million in 2021. It is expected to reach USD 8,486.98 million by 2030, growing at a CAGR of 4.67% during the forecast period (2022–2030).
In a minimally invasive surgical procedure, a vessel sealing device is used to cut, coagulate, separate, and seal the blood vessels. Various energy types are frequently used to seal the vessels, covering bipolar, ultrasonic, and hybrid energy types. In the vascular sealing devices' active electrodes circuit, an AC is directed at the appropriate tissue. Several factors, including dependability and efficiency, are considered when selecting the proper vessel sealing devices. These tools effectively seal vessels with a diameter of 7 mm. These devices' benefits include being extremely safe and effective and requiring less time to seal the blood vessels. Additionally, when performing surgery, using the right tools ensures that the peripheral cells experience the least amount of lateral spread.
The primary factor influencing the growth of the global vessel sealing devices market is the rising number of surgical procedures, which are primarily brought on by accidents, sports-related injuries, and cardiac surgeries caused by the high prevalence of cardiovascular diseases and other chronic conditions where the surgery is deemed necessary. The market demand for vessel sealing devices is anticipated to be driven by the growing preference for minimally invasive surgeries. An energy source is necessary for minimally invasive surgery to cut tissues and control hemostasis. Robotic surgical tools have also changed how minimally invasive surgery is performed, and surgeons' acceptance of these tools is growing globally. According to cohort research by Kyle H. Sheetz, the utilization of robotic surgery climbed from 1.8% in 2012 to 15.1% in 2018, a rise of 8.4% in 2019. Therefore, the market for vessel sealing devices is anticipated to grow during the forecast period, along with the increase in surgical procedures performed worldwide.
Despite vessel sealing devices' many benefits, some drawbacks could limit the market growth. Due to lateral thermal energy spread, vessel sealing systems can harm bowels, ureters, and nerves. This lateral energy spread damages 2 mm of tissue. According to a 2020 article by Shosaburo Oyama, LigaSure can cause complications during surgery. LigaSure cannot clamp essential blood vessels and nerves because large, dense tissues cannot fit between blades. Using this device during routine procedures, such as considerable organ bleeding, would be difficult. Generator failure can exacerbate blood loss and vessel damage.
Additionally, surgeons are not given formal training on these devices and are not required to document their safe use. No evaluation of how safely they use these devices increases the risk of damaging nearby structures. During vessel sealing, toxic smoke can harm patients and medical staff. Bipolar vessel sealing devices are expensive compared to other devices, and equipment disposal incurs additional costs. The business is anticipated to be hampered by problems with vessel sealing devices.
Bleeding is the main challenge in minimally invasive surgery. As a result, there is a growing need to enhance hemostasis, which has sped up the development of electrosurgical technology. The market is anticipated to have a broader scope due to the growing advancement in minimally invasive therapy and upcoming developments in vessel sealing devices to improve surgical safety, quality, and outcomes. Additionally, the prevalence of chronic diseases is rising globally, and the longer lifespan of those with chronic conditions contributes to the rise in surgical procedures. The number of surgical procedures will rise in the coming years, directly fueling market expansion. As a result, the regional market is being impressively fueled by the presence of many players.
By region, the global vessel sealing devices market is segmented into North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.
North America is the most significant shareholder in the global vessel sealing devices market and is expected to grow at a CAGR of 4.45% during the forecast period. The majority of the increase is primarily due to the rising incidence of chronic diseases, the FDA's approval of more and more new devices, the growing use of surgical interventions by the American public, and the rise in the proportion of minimally invasive surgical procedures performed in the nation. One in seven deaths in the United States is caused by heart disease, according to the American Heart Association Research Report 2018. In the United States, coronary heart disease (CHD) ranks first among causes of death from CVD (43.8%), followed by stroke (16.8%), heart failure (9.0%), high blood pressure (9.4%), diseases of the arteries (3.1%), and other CVDs (17.9%). Due to the increased frequency of CVDs, there will certainly be a rise in demand for vessel-sealing devices because so many people require heart operations for severe cardiac diseases.
Europe is expected to grow at a CAGR of 4.26%, generating USD 2,207.22 million during the forecast period. Germany has a sizable base of foreign firms focusing on creating goods due to the rising frequency of various diseases, the rising number of surgical procedures, and the rising geriatric population in the country, which is projected to boost the vessel sealing devices market. As a result, the country's growing use of vessel-sealing devices is also driven by the rising number of organ transplants. Additionally, vascular sealing is found to be a successful technique for attaining hemostasis by sealing both venous and arterial branches of the principal renal vessels of the donor and recipient during nephrectomy and hepatectomy procedures for organ donation. As a result, the aforementioned elements are boosting the German market, which is expected to boost market growth.
Asia-Pacific is anticipated to grow significantly during the forecast period. The Japanese healthcare industry has experienced rapid growth over the past few years. The nation also has a sizable number of hospitals and a highly developed healthcare infrastructure in the Asia-Pacific region. Additionally, it is anticipated that the rise in surgical procedures will increase demand for several procedures, increasing demand for vessel sealing devices. Although vessel-sealing devices (VSDs) are commonly utilized in Japan for various surgical procedures, including thoracoscopic surgery, relatively few studies have compared their efficacy and safety to thoracoscopic lobectomy operations in humans. Japan's three most widely used disposable vessel-sealing tools are EnSeal, LigaSure, and Harmonic. According to the International Society of Aesthetic Plastic Surgery, Japan saw 231,457 face and head surgeries in 2019. Surgery for the body and extremities is also practiced, with 11,623 procedures carried out that year (2019). Therefore, it is assumed that the vessel sealing devices market is well-established in Japan and will experience growth over the forecast period due to the factors above.
Saudi Arabia, Kuwait, Bahrain, Qatar, the United Arab Emirates (UAE), and Oman are the six nations that make up the GCC region. The GCC nations share social and economic backgrounds, health problems, and nearly identical health systems and policies. In 2018, 5.6 million Arabs interested in cosmetic procedures visited Tajmeeli.com to learn more about these procedures. A website called Tajmeeli provides information on cosmetic surgery to inform, assist, and empower people all over the Middle East. Additionally, a study from the Dubai government (2018) stated that there were roughly 26,000 operations performed in 2018, with 2,208 operations performed each day on average. Thirteen thousand seven hundred seventy-one primary operations, or 52% of surgeries, were performed. The rising frequency of surgical procedures has driven the demand for vessel-sealing devices.
The Brazilian market for vessel sealing devices is anticipated to grow at a healthy rate over the forecast period. Brazil is rising in popularity as one of the top locations for medical travel, and practical procedures like plastic surgery are carried out at reasonable costs. For laparoscopic surgeries, vessel sealing devices are crucial. Additionally, 1,493,673 cosmetic surgical procedures were performed in Brazil in 2019, according to statistics from the International Society of Aesthetic Plastic Surgery (ISAPS).
|Medtronic PLC B Braun Melsungen AG Erbe Medical India Pvt. Ltd Olympus Corporation Ethicon US LLC (Johnson & Johnson) Boston Scientific Corporation BOWA-electronic GmbH & Co. KG OmniGuide Holdings Inc. CONMED Corporation Bolder Surgical Holdings Inc
|U.K. Germany France Spain Italy Russia Nordic Benelux Rest of Europe
|China Korea Japan India Australia Taiwan South East Asia Rest of Asia-Pacific
|Middle East and Africa
|UAE Turkey Saudi Arabia South Africa Egypt Nigeria Rest of MEA
|Brazil Mexico Argentina Chile Colombia Rest of LATAM
|Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
The global vessel sealing devices market is segmented by product, application, and end-user.
Based on product, the global vessel sealing devices market is bifurcated into generators, instruments, and accessories.
The generators segment is the highest contributor to the market and is expected to grow at a CAGR of 4.14% during the forecast period. Electrosurgical generators, known as vessel sealing generators, supply power for bipolar and vessel sealing procedures. In minimally invasive surgery, the use of energy devices for vessel sealing and dissection is rising. In order to achieve a complete and lasting fusion of the vessel lumen, these generators deliver precise energy and electrode pressure to vessels for a predetermined time. The market is expanding due to rising demand for vessel sealing devices due to patients' increased interest in minimally invasive procedures and rising consumer acceptance of devices for surgical interventions like those for inflammatory bowel diseases and obesity.
The vessel sealing dissector and sealer/divider are part of the segment for vessel sealing instruments. An all-in-one instrument that can seal, cauterize, and safely cut soft tissue uses a generator connected to an electric cord. The market is anticipated to grow as a result of factors like rising surgical procedures, expanding target patient pools, and increasing patient demand for minimally invasive treatments. The last few years have seen a rise in technological advancement, which has created numerous opportunities for the market to grow. Endoscopic tissue sealers are frequently used in surgeries for routine procedures like hysterectomies and gall bladder removals. During the forecast period, usage of these systems is expected to rise due to accompanying benefits like decreased adhesions and thermal spread during surgical intervention.
Based on application, the global vessel sealing device market is bifurcated into general and laparoscopic surgery.
The general surgery segment owns the highest market share and is expected to grow at a CAGR of 4.50% during the forecast period. General surgery covers various operative techniques for diagnosing and treating illnesses and injuries in any body area. Increased demand for inexpensive vessel sealing devices for general surgeries, an increase in the number of patients undergoing surgical procedures, and an increase in the incidence of chronic diseases are all cited as reasons for the high market growth. The most common illnesses found to affect people worldwide are cardiovascular diseases, which are also the leading causes of death. According to WHO updates for 2020, 16% of all deaths worldwide are caused by ischemic heart disease. Ischemic heart disease has seen the most significant increase in deaths since 2000, rising by more than 2 million to 8.9 million deaths in 2019. These conditions are the most frequent ones that result in general surgeries, which helps the segment grow.
A surgical diagnostic technique called laparoscopy examines the organs inside the abdomen. For this minimally invasive technique, only a few tiny incisions are required. The abdominal organs are viewed during laparoscopy using a device called a laparoscope. The main tools used in laparoscopic surgeries to close the vessels opened during the procedure are vessel sealing devices. The main factors propelling the segment's growth are the growing understanding of the benefits of laparoscopic procedures over open surgeries and the rise in laparoscopic procedures performed globally. Bipolar diathermy and ultrasonic technology are used to construct advanced vessel sealing devices to improve vessel sealing efficiency and more reliable hemostasis during laparoscopic surgery.
Based on the end-user, the global vessel sealing device market is bifurcated into hospitals and specialty clinics, and ambulatory surgical centers.
The hospitals and specialty clinics segment is the highest contributor to the market and is expected to grow at a CAGR of 4.86% during the forecast period. Since hospitals perform most surgeries, they hold a sizable portion of the market for vessel sealing devices. Vessel sealing devices are utilized more commonly in hospitals and clinics, where surgical procedures are becoming more prevalent, to lessen blood loss, infection rates, and operating time. Most laparoscopic surgical procedures, including bariatric, gynecologic, and gall bladder surgery, are carried out in hospitals due to the ease of handling emergencies during surgical procedures or post-operative complications. Therefore, it is crucial to consider how vessel sealing devices are used in surgical procedures; as a result, the market for these devices is anticipated to proliferate during the forecast period.
Ambulatory surgery centers, or ASCs, are cutting-edge medical establishments that offer same-day surgical care, including diagnostic and preventive procedures. Additionally, several studies and surveys have been conducted about ambulatory laparoscopy surgical procedures. For instance, a 2020 NIH study on laparoscopic-assisted myomectomy in ambulatory settings found benefits, including higher efficiency, lower costs than hospitals, and patient convenience. As a result, the market is anticipated to grow significantly during the forecast period as demand for vessel sealing systems rises along with the number of ambulatory surgeries.